Bio-View Ltd (TLV: BIOV)
Israel
· Delayed Price · Currency is ILS · Price in ILA29.40
+1.10 (3.89%)
Oct 15, 2024, 5:24 PM IDT
Bio-View Income Statement
Financials in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 34.34 | 34.77 | 29.15 | 30.51 | 25.96 | 35.79 | Upgrade
|
| Revenue Growth (YoY) | 0.67% | 19.29% | -4.48% | 17.54% | -27.47% | 41.57% | Upgrade
|
| Cost of Revenue | 12.07 | 13.39 | 12.48 | 12.93 | 10.18 | 15.52 | Upgrade
|
| Gross Profit | 22.28 | 21.38 | 16.67 | 17.59 | 15.78 | 20.27 | Upgrade
|
| Selling, General & Admin | 13.25 | 12.83 | 11.72 | 9.7 | 8.77 | 10.22 | Upgrade
|
| Research & Development | 8.93 | 8.41 | 4.85 | 5.33 | 5.35 | 5.71 | Upgrade
|
| Other Operating Expenses | - | - | - | - | 0.46 | -0.02 | Upgrade
|
| Operating Expenses | 22.19 | 21.24 | 16.57 | 15.03 | 14.58 | 15.91 | Upgrade
|
| Operating Income | 0.09 | 0.14 | 0.1 | 2.56 | 1.2 | 4.36 | Upgrade
|
| Interest Expense | -0.35 | -0.31 | -0.24 | -0.23 | -0.05 | -0.06 | Upgrade
|
| Interest & Investment Income | 1.4 | 0.44 | 0.03 | 0.02 | 0.04 | 0.09 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.14 | 0.14 | 1.05 | -0.59 | - | -0.96 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.1 | -0.1 | -0.07 | -0.06 | -0.06 | -0.05 | Upgrade
|
| EBT Excluding Unusual Items | 0.91 | 0.3 | 0.88 | 1.7 | 1.14 | 3.37 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | -0.01 | - | - | Upgrade
|
| Other Unusual Items | 0.49 | 0.49 | - | 0.99 | - | - | Upgrade
|
| Pretax Income | 1.4 | 0.8 | 0.88 | 2.68 | 1.14 | 3.37 | Upgrade
|
| Income Tax Expense | 0.52 | 0.41 | 0.29 | 0.5 | 0.26 | 0.84 | Upgrade
|
| Net Income | 0.89 | 0.38 | 0.59 | 2.18 | 0.88 | 2.53 | Upgrade
|
| Net Income to Common | 0.89 | 0.38 | 0.59 | 2.18 | 0.88 | 2.53 | Upgrade
|
| Net Income Growth | -57.84% | -34.75% | -73.12% | 147.06% | -64.99% | - | Upgrade
|
| Shares Outstanding (Basic) | 135 | 135 | 139 | 140 | 141 | 142 | Upgrade
|
| Shares Outstanding (Diluted) | 141 | 140 | 139 | 140 | 141 | 142 | Upgrade
|
| Shares Change (YoY) | -28.39% | 0.75% | -0.49% | -0.60% | -0.93% | 0.47% | Upgrade
|
| EPS (Basic) | 0.01 | 0.00 | 0.00 | 0.02 | 0.01 | 0.02 | Upgrade
|
| EPS (Diluted) | 0.01 | 0.00 | 0.00 | 0.02 | 0.01 | 0.02 | Upgrade
|
| EPS Growth | -42.94% | -32.99% | -72.99% | 160.43% | -66.27% | - | Upgrade
|
| Free Cash Flow | -1.31 | -0.12 | 0.51 | 2.59 | 0.5 | 2.29 | Upgrade
|
| Free Cash Flow Per Share | -0.01 | -0.00 | 0.00 | 0.02 | 0.00 | 0.02 | Upgrade
|
| Gross Margin | 64.86% | 61.48% | 57.20% | 57.63% | 60.80% | 56.63% | Upgrade
|
| Operating Margin | 0.26% | 0.39% | 0.35% | 8.38% | 4.63% | 12.18% | Upgrade
|
| Profit Margin | 2.58% | 1.10% | 2.01% | 7.16% | 3.41% | 7.06% | Upgrade
|
| Free Cash Flow Margin | -3.81% | -0.35% | 1.75% | 8.48% | 1.92% | 6.39% | Upgrade
|
| EBITDA | 0.45 | 0.46 | 0.36 | 4.03 | 2.43 | 5.76 | Upgrade
|
| EBITDA Margin | 1.32% | 1.31% | 1.25% | 13.22% | 9.36% | 16.09% | Upgrade
|
| D&A For EBITDA | 0.36 | 0.32 | 0.26 | 1.48 | 1.23 | 1.4 | Upgrade
|
| EBIT | 0.09 | 0.14 | 0.1 | 2.56 | 1.2 | 4.36 | Upgrade
|
| EBIT Margin | 0.26% | 0.39% | 0.35% | 8.38% | 4.63% | 12.18% | Upgrade
|
| Effective Tax Rate | 36.78% | 51.94% | 32.91% | 18.60% | 22.52% | 25.03% | Upgrade
|
| Advertising Expenses | - | 0.12 | 0.17 | 0.04 | 0.11 | 0.18 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.